Lupin partners with Takeda to launch novel gastrointestinal drug Vonoprazan in India
In a significant development, Lupin Limited, a global pharmaceutical leader, announced a non-exclusive patent licence agreement with Takeda Pharmaceutical Company Limited to commercialise Vonoprazan Tablets ... Read More
LupinLife launches Ayurvedic liquid laxative Softovac Liquifibre
LupinLife, the consumer healthcare division of global pharmaceutical giant Lupin Limited, announced a significant entry into the Indian liquid laxative market with the launch of ... Read More
Lupin acquires five legacy brands, intensifies Indian pharma dominance
In a move that has set the pharmaceutical industry abuzz, global pharma titan Lupin Limited has revealed the acquisition of five key legacy brands, zeroing ... Read More
Lupin acquires diabetes brands ONDERO and ONDERO MET from Boehringer Ingelheim
In a strategic move to fortify its position in the pharmaceutical domain, global major Lupin Limited proclaimed its acquisition of coveted diabetes brands ONDERO and ... Read More
Lupin Digital Health unveils Lyfe Digital Heart Failure Clinic
Indian cardiac digital therapeutics entity, Lupin Digital Health (LDH), marked another achievement with the unveiling of its Lyfe Digital Heart Failure Clinic. Designed to cater ... Read More
Lupin, Enzene Biosciences to launch cancer drug Cetuximab biosimilar in India
Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories, to introduce Cetuximab in India. Cetuximab is ... Read More